Skip to content
MatchScript
Menu
Ranked #18 · Grade B

REMEVi review

A straightforward, nationwide program with both molecules at mid-market pricing and LegitScript certification.

Visit REMEVi Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
Semaglutide
$199/mo
Tirzepatide
$269/mo
Coverage
All 50 states
Brand-name
Compounded only

The factor breakdown

REMEVi scored on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.

Budget Fit78/100
Speed to Start88/100
Formulary Match80/100
Support Level84/100
Flexibility84/100
Transparency86/100

What we like

  • Both molecules offered at sensible mid-market pricing
  • Available in all 50 states and LegitScript-certified
  • Clear, upfront pricing

The caveats

  • No oral/sublingual option or brand-name access
  • Support is standard rather than high-touch

Who it matches

Best for: People who want a verified, all-50-state injectable program without paying premium prices. A straightforward, nationwide program with both molecules at mid-market pricing and LegitScript certification.

Ranked #18 of 25 providers under our default weighting — see our #1 pick, CoreAge Rx, or take the quiz to see where REMEVi lands for you.

Compare with other providers

All 24 other providers we've reviewed, in our default ranking order.

Pricing, states and verification reflect REMEVi's public disclosures at last review; the Match Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to all rankings